A New Genetic Culprit for a Spectrum of Neuropathies
A major international study has revealed the extraordinary phenotypic diversity of Charcot-Marie-Tooth disease (CMT) caused by heterozygous variants in the SLC12A6 gene. Published in the Journal of Neurology, Neurosurgery & Psychiatry, the research analyzed 23 patients from 13 families across four continents. The findings demonstrate that specific genetic mutations in SLC12A6 can lead to the full spectrum of CMT clinical presentations, from severe childhood-onset sensory and motor neuropathies with slowed nerve conduction to mild adult-onset sensory-predominant forms and even infantile-onset motor neuropathies. This genotype-phenotype correlation, unprecedented in its diversity for a single CMT gene, underscores the critical role of SLC12A6 in peripheral nerve function and highlights the necessity of comprehensive genetic screening for accurate diagnosis and future therapeutic development.
Study Significance: For specialists in infectious diseases and host-pathogen interactions, this research offers a compelling parallel in understanding genetic determinants of disease severity. The study’s model of how single-gene variants dictate a wide range of clinical outcomes—from mild to severe—mirrors the complex interplay seen in infectious diseases, where host genetics critically influence susceptibility and progression. This work reinforces the importance of precision medicine approaches, suggesting that future management of neuropathies, and by extension complex infections, will increasingly depend on detailed genetic profiling to predict clinical course and tailor interventions.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
